Copenhagen, 10 June 2014 – Zealand Pharma A/S (“Zealand”) (NASDAQ OMX Copenhagen: ZEAL) informs that new data will be presented on four products from the company’s portfolio of novel diabetes peptide therapeutics at the upcoming 74th Scientific Sessions of the American Diabetes Association (ADA) to be held in San Francisco, 13-17 June 2014.
Help employers find you! Check out all the jobs and post your resume.
